Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The emerging field of gut-lung axis research has revealed a complex interplay between the gut microbiota and respiratory health, particularly in asthma. This review comprehensively explored the intricate relationship between these two systems, focusing on their influence on immune responses, inflammation, and the pathogenesis of respiratory diseases. Recent studies have demonstrated that gut microbiota dysbiosis can contribute to asthma onset and exacerbation, prompting investigations into therapeutic strategies to correct this imbalance. Probiotics and prebiotics, known for their ability to modulate gut microbial compositions, were discussed as potential interventions to restore immune homeostasis. The impact of antibiotics and metabolites, including short-chain fatty acids produced by the gut microbiota, on immune regulation was examined. Fecal microbiota transplantation has shown promise in various diseases, but its role in respiratory disorders is not established. Innovative approaches, including mucus transplants, inhaled probiotics, and microencapsulation strategies, have been proposed as novel therapeutic avenues. Despite challenges, including the sophisticated adaptability of microbial communities and the need for mechanistic clarity, the potential for microbiota-based interventions is considerable. Collaboration between researchers, clinicians, and other experts is essential to unravel the complexities of the gut-lung axis, paving a way for innovative strategies that could transform the management of respiratory diseases.
Abstract
The emerging field of gut-lung axis research has revealed a complex interplay between the gut microbiota and respiratory health, particularly in asthma. This review comprehensively explored the intricate relationship between these two systems, focusing on their influence on immune responses, inflammation, and the pathogenesis of respiratory diseases. Recent studies have demonstrated that gut microbiota dysbiosis can contribute to asthma onset and exacerbation, prompting investigations into therapeutic strategies to correct this imbalance. Probiotics and prebiotics, known for their ability to modulate gut microbial compositions, were discussed as potential interventions to restore immune homeostasis. The impact of antibiotics and metabolites, including short-chain fatty acids produced by the gut microbiota, on immune regulation was examined. Fecal microbiota transplantation has shown promise in various diseases, but its role in respiratory disorders is not established. Innovative approaches, including mucus transplants, inhaled probiotics, and microencapsulation strategies, have been proposed as novel therapeutic avenues. Despite challenges, including the sophisticated adaptability of microbial communities and the need for mechanistic clarity, the potential for microbiota-based interventions is considerable. Collaboration between researchers, clinicians, and other experts is essential to unravel the complexities of the gut-lung axis, paving a way for innovative strategies that could transform the management of respiratory diseases.
참고문헌 (107)
- Turner PV, "The role of the gut microbiota on animal model reproducibility", Animal Model Exp Med, 1, pp.109~115 (2018)
- Mackie RI, "Developmental microbial ecology of the neonatal gastrointestinal tract", Am J Clin Nutr, 69, pp.1035S~1045S (1999)
- Ley RE, "Ecological and evolutionary forces shaping microbial diversity in the human intestine", Cell, 124, pp.837~848 (2006)
- Hooper LV, "Interactions between the microbiota and the immune system", Science, 336, pp.1268~1273 (2012)
- Thursby E, "Introduction to the human gut microbiota", Biochem J, 474, pp.1823~1836 (2017)
- Lynch SV, "The human intestinal microbiome in health and disease", N Engl J Med, 375, pp.2369~2379 (2016)
- Valdes AM, "Role of the gut microbiota in nutrition and health", BMJ, 361, pp.k2179~ (2018)
- Gensollen T, "How colonization by microbiota in early life shapes the immune system", Science, 352(6285), pp.539~544 (2016)
- Celebi Sozener Z, "Epithelial barrier hypothesis : effect of the external exposome on the microbiome and epithelial barriers in allergic disease", Allergy, 77, pp.1418~1449 (2022)
- Sohn KH, "Alteration of lung and gut microbiota in IL-13-transgenic mice simulating chronic asthma", J Microbiol Biotechnol, 30, pp.1819~1826 (2020)
- Brusselle GG, "Biologic therapies for severe asthma", N Engl J Med, 386, pp.157~171 (2022)
- Herbst T, "Dysregulation of allergic airway inflammation in the absence of microbial colonization", Am J Respir Crit Care Med, 184, pp.198~205 (2011)
- Remot A, "Bacteria isolated from lung modulate asthma susceptibility in mice", ISME J, 11, pp.1061~1074 (2017)
- van Nimwegen FA, "Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy", J Allergy Clin Immunol, 128, pp.948~955 (2011)
- Johnson CC, "Antibiotic exposure in early infancy and risk for childhood atopy", J Allergy Clin Immunol, 115, pp.1218~1224 (2005)
- Fujimura KE, "Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation", Nat Med, 22, pp.1187~1191 (2016)
- Arrieta MC, "Early infancy microbial and metabolic alterations affect risk of childhood asthma", Sci Transl Med, 7, pp.307ra152~ (2015)
- Begley L, "Gut microbiota relationships to lung function and adult asthma phenotype : a pilot study", BMJ Open Respir Res, 5, pp.e000324~ (2018)
- Fujimura KE, "House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection", Proc Natl Acad Sci U S A, 111, pp.805~810 (2014)
- Johansson MA, "Early colonization with a group of Lactobacilli decreases the risk for allergy at five years of age despite allergic heredity", PLoS One, 6, pp.e23031~ (2011)
- Sagar S, "Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma", Respir Res, 15, pp.46~ (2014)
- Raftis EJ, "Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration", Sci Rep, 8, pp.12024~ (2018)
- Sagar S, "The combination of Bifidobacterium breve with non-digestible oligosaccharides suppresses airway inflammation in a murine model for chronic asthma", Biochim Biophys Acta, 1842, pp.573~583 (2014)
- Atarashi K, "Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota", Nature, 500(7461), pp.232~236 (2013)
- O’Mahony C, "Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation", PLoS Pathog, 4, pp.e1000112~ (2008)
- de Groot P, "Faecal microbiota transplantation halts progression of human new-onset type 1diabetes in a randomised controlled trial", Gut, 70, pp.92~105 (2021)
- Karimi K, "Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice", Am J Respir Crit Care Med, 179, pp.186~193 (2009)
- Li YN, "Effect of oral feeding with Clostridium leptum on regulatory T-cell responses and allergic airway inflammation in mice", Ann Allergy Asthma Immunol, 109, pp.201~207 (2012)
- Michalovich D, "Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients", Nat Commun, 10, pp.5711~ (2019)
- Demirci M, "Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma", Allergol Immunopathol(Madr), 47, pp.365~371 (2019)
- Penders J, "Factors influencing the composition of the intestinal microbiota in early infancy", Pediatrics, 118, pp.511~521 (2006)
- Roduit C, "High levels of butyrate and propionate in early life are associated with protection against atopy", Allergy, 74, pp.799~809 (2019)
- Di Vincenzo F, "Bile acid-related regulation of mucosal inflammation and intestinal motility : from pathogenesis to therapeutic application in IBD and microscopic colitis", Nutrients, 14, pp.2664~ (2022)
- Joyce SA, "Disease-associated changes in bile acid profiles and links to altered gut microbiota", Dig Dis, 35, pp.169~177 (2017)
- Willart MA, "Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor", Allergy, 67, pp.1501~1510 (2012)
- Nakada EM, "Conjugated bile acids attenuate allergen-induced airway inflammation and hyperresponsiveness by inhibiting UPR transducers", JCI Insight, 4, pp.e98101~ (2019)
- Kelly RS, "Plasma metabolite profiles in children with current asthma", Clin Exp Allergy, 48, pp.1297~1304 (2018)
- Comhair SA, "Metabolomic endotype of asthma", J Immunol, 195, pp.643~650 (2015)
- Mantis NJ, "Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut", Mucosal Immunol, 4, pp.603~611 (2011)
- Hapfelmeier S, "Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses", Science, 328, pp.1705~1709 (2010)
- Nakajima A, "IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria", J Exp Med, 215, pp.2019~2034 (2018)
- Kilian M, "Biological significance of IgA1 proteases in bacterial colonization and pathogenesis : critical evaluation of experimental evidence", APMIS, 104, pp.321~338 (1996)
- Wang X, "SIgA in various pulmonary diseases", Eur J Med Res, 28, pp.299~ (2023)
- Gu BH, "Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome", Allergy, 78, pp.1909~1921 (2023)
- Sohn KH, "Different inflammatory features of asthma according to gut microbiome enterotype", Allergy, 78, pp.2997~3001 (2023)
- Rabe KF, "Chronic obstructive pulmonary disease", Lancet, 389, pp.1931~1940 (2017)
- Quan Y, "The gut-lung axis : gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin", Front Pharmacol, 13, pp.985223~ (2022)
- Bowerman KL, "Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease", Nat Commun, 11, pp.5886~ (2020)
- Lee SH, "Association between cigarette smoking status and composition of gut microbiota : population-based cross-sectional study", J Clin Med, 7, pp.282~ (2018)
- Tanner L, "Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders : translating pre-clinical data into clinical relevance", J Innate Immun, 12, pp.203~225 (2020)
- Li N, "Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease", Respir Res, 22, pp.274~ (2021)
- Lai HC, "Gut microbiota modulates COPD pathogenesis : role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide", Gut, 71, pp.309~321 (2022)
- Liu Y, "The gut microbiome is a significant risk factor for future chronic lung disease", J Allergy Clin Immunol, 151, pp.943~952 (2023)
- Molyneaux PL, "The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis", Am J Respir Crit Care Med, 190, pp.906~913 (2014)
- Molyneaux PL, "Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis", Respir Res, 18, pp.29~ (2017)
- Han MK, "Lung microbiome and disease progression in idiopathic pulmonary fibrosis : an analysis of the COMET study", Lancet Respir Med, 2, pp.548~556 (2014)
- Chioma OS, "Gut microbiota modulates lung fibrosis severity following acute lung injury in mice", Commun Biol, 5, pp.1401~ (2022)
- Durack J, "Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation", Nat Commun, 9, pp.707~ (2018)
- Dzidic M, "Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development", J Allergy Clin Immunol, 139, pp.1017~1025 (2017)
- Liu Y, "Probiotics in disease prevention and treatment", J Clin Pharmacol, 58(Suppl 10), pp.S164~S179 (2018)
- Wang W, "Bifidobacterium infantis relieves allergic asthma in mice by regulating Th1", Th2, 2020, pp.26, e920583~
- Navarro S, "The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways", Mucosal Immunol, 4, pp.53~65 (2011)
- Wu Z, "Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4", NF-kB signaling pathway, 2022, pp.20, 130~
- Antunes KH, "Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response", Nat Commun, 10, pp.3273~ (2019)
- Trompette A, "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis", Nat Med, 20, pp.159~166 (2014)
- Vieira RS, "Butyrate attenuates lung inflammation by negatively modulating Th9 cells", Front Immunol, 10, pp.67~ (2019)
- Park HK, "Altered gut microbiota by azithromycin attenuates airway inflammation in allergic asthma", J Allergy Clin Immunol, 145, pp.1466~1469 (2020)
- Wei S, "Short-and longterm impacts of azithromycin treatment on the gut microbiota in children : a double-blind, randomized, placebo-controlled trial", EBioMedicine, 38, pp.265~272 (2018)
- Trivedi R, "Gut microbiome a promising target for management of respiratory diseases", Biochem J, 477, pp.2679~2696 (2020)
- Shah P, "A microfluidics-based in vitro model of the gastrointestinal human-microbe interface", Nat Commun, 7, pp.11535~ (2016)
- Gibson GR, "Expert consensus document : The International Scientific Association for Probiotics and Prebiotics(ISAPP)consensus statement on the definition and scope of prebiotics", Nat Rev Gastroenterol Hepatol, 14, pp.491~502 (2017)
- Williams NT, "Probiotics", Am J Health Syst Pharm, 67, pp.449~458 (2010)
- Ramakrishna BS, "Role of the gut microbiota in human nutrition and metabolism", J Gastroenterol Hepatol, 28(Suppl 4), pp.9~17 (2013)
- Matsusaki T, "Augmentation of T helper type 1 immune response through intestinal immunity in murine cutaneous herpes simplex virus type 1 infection by probiotic Lactobacillus plantarum strain 06CC2", Int Immunopharmacol, 39, pp.320~327 (2016)
- Won TJ, "Modulation of Th1", Th2 balance by Lactobacillus strains isolated from Kimchi via stimulation of macrophage cell line J774A. 1 in vitro, 2011, pp.76, H55~H61
- Lee DH, "Immunoregulatory effects of Lactococcus lactis-derived extracellular vesicles in allergic asthma", Clin Transl Allergy, 12, pp.e12138~ (2022)
- Bermudez-Brito M, "Probiotic mechanisms of action", Ann Nutr Metab, 61, pp.160~174 (2012)
- Fernando WMADB, "The potential synergistic behaviour of inter-and intra-genus probiotic combinations in the pattern and rate of short chain fatty acids formation during fibre fermentation", Int J Food Sci Nutr, 69, pp.144~154 (2018)
- Niessen NM, "Airway monocyte modulation relates to tumour necrosis factor dysregulation in neutrophilic asthma", ERJ Open Res, 7, pp.00131-2021~ (2021)
- Niessen NM, "Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment", Allergy, 76, pp.2090~2101 (2021)
- Korpela K, "Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children", Nat Commun, 7, pp.10410~ (2016)
- Kelly CJ, "Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function", Cell Host Microbe, 17, pp.662~671 (2015)
- Furusawa Y, "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells", Nature, 504, pp.446~450 (2013)
- Zelante T, "Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22", Immunity, 39, pp.372~385 (2013)
- Viladomiu M, "Modulation of inflammation and immunity by dietary conjugated linoleic acid", Eur J Pharmacol, 785, pp.87~95 (2016)
- Sun M, "Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases", J Gastroenterol, 52, pp.1~8 (2017)
- Wong AC, "New approaches to microbiome-based therapies", mSystems, 4, pp.e00122-19~ (2019)
- Cait A, "Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids", Mucosal Immunol, 11, pp.785~795 (2018)
- Lee-Sarwar KA, "Fecal short-chain fatty acids in pregnancy and offspring asthma and allergic outcomes", J Allergy Clin Immunol Pract, 8, pp.1100~1102 (2020)
- Levy M, "Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling", cell, 163, pp.1428~1443 (2015)
- Gao C, "Histamine H2 receptor-mediated suppression of intestinal inflammation by probiotic Lactobacillus reuteri", mBio, 6, pp.e01358-15~ (2015)
- Rutting S, "Short-chain fatty acids increase TNFα-induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK", Am J Physiol Lung Cell Mol Physiol, 316, pp.L157~L174 (2019)
- Kelly CR, "Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection : a randomized trial", Ann Intern Med, 165, pp.609~616 (2016)
- Costello SP, "Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis : a randomized clinical trial", JAMA, 321, pp.156~164 (2019)
- Leong KSW, "Effects of fecal microbiome transfer in adolescents with obesity : the gut bugs randomized controlled trial", JAMA Netw Open, 3, pp.e2030415~ (2020)
- Kang DW, "Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota", Sci Rep, 9, pp.5821~ (2019)
- Wilson NG, "The gut microbiota of people with asthma influences lung inflammation in gnotobiotic mice", iScience, 26, pp.105991~ (2023)
- Umesaki Y, "Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse", Microbiol Immunol, 39, pp.555~562 (1995)
- Ekmekciu I, "Immune responses to broad-spectrum antibiotic treatment and fecal microbiota transplantation in mice", Front Immunol, 8, pp.397~ (2017)
- Zhou Y, "The upper-airway microbiota and loss of asthma control among asthmatic children", Nat Commun, 10, pp.5714~ (2019)
- Huang YJ, "Asthma microbiome studies and the potential for new therapeutic strategies", Curr Allergy Asthma Rep, 13, pp.453~461 (2013)
- Kim YC, "Selenomonas : a marker of asthma severity with the potential therapeutic effect", Allergy, 77, pp.317~320 (2022)
- Mårtensson A, "Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis : a randomized controlled trial", Laryngoscope Investig Otolaryngol, 2, pp.410~416 (2017)
- Myles IA, "First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis", JCI Insight, 3, pp.e120608~ (2018)
- David LA, "Diet rapidly and reproducibly alters the human gut microbiome", Nature, 505, pp.559~563 (2014)
- Gupta VK, "Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity", Front Microbiol, 8, pp.1162~ (2017)
- Scherzer R, "Heterogeneity and the origins of asthma", Ann Allergy Asthma Immunol, 121, pp.400~405 (2018)
